RP
Repare Therapeutics Inc.
RPTX · NASDAQ
$2.58 +0.19% (+$0.01)
Market Cap $110.5M
P/E Ratio -
Div. Yield -
ROE 57.56%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/S 9.31x
P/B 0.96x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 86.18%
Net margin 608.26%
Op. margin 632.62%
Quality
1 /100
Poor ROIC 65.98%
ROE 57.56%
ROA 56.96%
Debt
94 /100
Low Debt/Equity 0.00x
Current ratio 10.71x
Net debt/EBITDA 1.01x
Stability
34 /100
Moderate Beta 0.96x
EPS volatility 98.83%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RPTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steve Forte
Employees
129
Headquarters
Montreal